Approved cancer drug may reduce kidney damage linked to nail-patella syndrome
Researchers led by Dr. Ralph Witzgall, a professor at the Chair of Molecular and Cellular Anatomy at the University of Regensburg, have deciphered a key disease mechanism underlying the hereditary kidney disorder nail-patella ...
Oct 7, 2026
0
7
